{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T03:47:37Z","timestamp":1792381657079,"version":"4.4.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/moo.0b013e32832d75e3","type":"journal-article","created":{"date-parts":[[2009,7,14]],"date-time":"2009-07-14T03:20:06Z","timestamp":1247541606000},"page":"315-320","source":"Crossref","is-referenced-by-count":19,"title":["Management of benign skin lesions commonly affecting the face: actinic keratosis, seborrheic keratosis, and rosacea"],"prefix":"10.1097","volume":"17","author":[{"given":"Jacob","family":"Brodsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210206","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000076016","article-title":"Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspects","volume":"17","author":"Oppel","year":"2004","journal-title":"Skin Pharmacol Physiol"},{"key":"R2-13-20210206","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1468-3083.2008.02579.x","article-title":"Actinic keratosis: an occupational and environmental disorder","volume":"22","author":"Schwartz","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R3-13-20210206","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-4632.2007.03166.x","article-title":"Actinic keratosis","volume":"46","author":"Rossi","year":"2007","journal-title":"Int J Dermatol"},{"key":"R4-13-20210206","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2008.01.042","article-title":"Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis","volume":"264","author":"Kanellou","year":"2008","journal-title":"Cancer Lett"},{"key":"R5-13-20210206","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1099\/vir.0.2008\/001925-0","article-title":"Four novel human betapapillomaviruses of species 2 preferentially found in actinic keratosis","volume":"89","author":"Vasiljevic","year":"2008","journal-title":"J Gen Virol"},{"key":"R6-13-20210206","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.oraloncology.2008.05.019","article-title":"Actinic cheilitis: epithelial expression of COX-2 and its association with mast cell tryptase and PAR-2","volume":"45","author":"Rojas","year":"2009","journal-title":"Oral Oncol"},{"key":"R7-13-20210206","first-page":"610","article-title":"Clinical applicability of in vivo reflectance confocal microscopy for the diagnosis of actinic keratoses","volume":"34","author":"Ulrich","year":"2008","journal-title":"Dermatol Surg"},{"key":"R8-13-20210206","first-page":"620","article-title":"Discrimination of actinic keratoses from normal skin with reflectance mode confocal microscopy","volume":"34","author":"Horn","year":"2008","journal-title":"Dermatol Surg"},{"key":"R9-13-20210206","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archdermatol.2008.562","article-title":"Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses","volume":"145","author":"Yentzer","year":"2009","journal-title":"Arch Dermatol"},{"key":"R10-13-20210206","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archderm.140.7.813","article-title":"Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial","volume":"140","author":"Jorizzo","year":"2004","journal-title":"Arch Dermatol"},{"key":"R11-13-20210206","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2008.08.039","article-title":"Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses","volume":"60","author":"Zeichner","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R12-13-20210206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1468-3083.2008.02943.x","article-title":"Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis","volume":"23","author":"Marks","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R13-13-20210206","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1468-3083.2008.02842.x","article-title":"Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: a case series","volume":"22","author":"Vlachou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R14-13-20210206","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2230.2008.02783.x","article-title":"Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses","volume":"34","author":"Mastrolonardo","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"R15-13-20210206","first-page":"669","article-title":"Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery","volume":"7","author":"Berlin","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"R16-13-20210206","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1517\/14740338.7.2.167","article-title":"The safety of diclofenac for the management and treatment of actinic keratoses","volume":"7","author":"Iraji","year":"2008","journal-title":"Exp Opin Drug Safety"},{"key":"R17-13-20210206","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/09546630701818870","article-title":"Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis","volume":"19","author":"Kose","year":"2008","journal-title":"J Dermatol Treat"},{"key":"R18-13-20210206","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0190-9622(94)70261-6","article-title":"Cryosurgery updated","volume":"31","author":"Kuflik","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"R19-13-20210206","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/lsm.20012","article-title":"Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and nonmelanoma skin cancer","volume":"34","author":"Iyer","year":"2004","journal-title":"Lasers Surg Med"},{"key":"R20-13-20210206","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1524-4725.1996.tb00565.x","article-title":"Dermabrasion for prophylaxis and treatment of actinic keratoses","volume":"22","author":"Coleman","year":"1996","journal-title":"Dermatol Surg"},{"key":"R21-13-20210206","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1751-1097.2007.00276.x","article-title":"Photodynamic therapy in the treatment of actinic keratosis","volume":"84","author":"Stritt","year":"2008","journal-title":"Photochem Photobiol"},{"key":"R22-13-20210206","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2008.05.031","article-title":"Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: a randomized, double-blind, placebo-controlled study","volume":"59","author":"Pariser","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R23-13-20210206","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1365-2133.2008.08450.x","article-title":"Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses: a randomized, controlled, single-blinded study","volume":"158","author":"Wiegell","year":"2008","journal-title":"Br J Dermatol"},{"key":"R24-13-20210206","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2230.2008.02755.x","article-title":"Nerve blocks provide effective pain relief during topical photodynamic therapy for extensive facial actinic keratoses","volume":"33","author":"Paoli","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"R25-13-20210206","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1610-0387.2008.06788.x","article-title":"Seborrheic keratosis","volume":"6","author":"Hafner","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"R26-13-20210206","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archderm.136.6.759","article-title":"The prevalence of seborrheic keratoses in people aged 15 to 30 years: is the term senile keratosis redundant?","volume":"136","author":"Gill","year":"2000","journal-title":"Arch Dermatol"},{"key":"R27-13-20210206","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1600-0560.2007.00920.x","article-title":"Incidental epidermodysplasia verruciformis human papillomavirus infection (EV acanthoma): evidence for \u2018field cancerization\u2019 and a putative cofactor in seborrheic keratosis","volume":"35","author":"Rohwedder","year":"2008","journal-title":"J Cut Pathol"},{"key":"R28-13-20210206","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1600-0560.2006.00579.x","article-title":"Changes of epidermodysplasia verruciformis in benign skin lesions: the EV acanthoma","volume":"34","author":"Ko","year":"2007","journal-title":"J Cut Pathol"},{"key":"R29-13-20210206","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jaad.2007.12.011","article-title":"Melanoma mimicking seborrheic keratosis: an error of perception precluding correct dermoscopic diagnosis","volume":"58","author":"Braga","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R31-13-20210206","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0733-8635(03)00057-3","article-title":"Laser eradication of pigmented lesions and tattoos","volume":"20","author":"Kilmer","year":"2002","journal-title":"Dermatol Clin"},{"key":"R32-13-20210206","first-page":"525","article-title":"532-nm diode laser treatment of seborrheic keratoses with color enhancement","volume":"34","author":"Culbertson","year":"2008","journal-title":"Dermatol Surg"},{"key":"R33-13-20210206","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1517\/14656566.9.15.2699","article-title":"Azelaic acid 15% gel in the treatment of rosacea","volume":"9","author":"Gollnick","year":"2008","journal-title":"Exp Opin Pharmacother"},{"key":"R34-13-20210206","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R35-13-20210206","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/09546630701485233","article-title":"The enigma of rosacea","volume":"18","author":"Marks","year":"2007","journal-title":"J Dermatol Treat"},{"key":"R36-13-20210206","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00403-007-0816-z","article-title":"A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process","volume":"300","author":"Aroni","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"R37-13-20210206","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1468-3083.2008.02778.x","article-title":"Contact allergy in patients with rosacea: a clinic-based, prospective epidemiological study","volume":"22","author":"Jappe","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R38-13-20210206","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-4632.2008.03445.x","article-title":"Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial","volume":"47","author":"Akhyani","year":"2008","journal-title":"Int J Dermatol"},{"key":"R39-13-20210206","first-page":"531","article-title":"American Acne & Rosacea Society rosacea medical management guidelines","volume":"7","author":"Del Rosso","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"R40-13-20210206","first-page":"573","article-title":"Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea","volume":"7","author":"Del Rosso","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"R41-13-20210206","first-page":"541","article-title":"Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea","volume":"7","author":"Thiboutot","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"R42-13-20210206","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaad.2006.04.084","article-title":"Systematic review of rosacea treatments","volume":"56","author":"Van Zuuren","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R43-13-20210206","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-3083.2008.02589.x","article-title":"A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea","volume":"22","author":"Karabulut","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R44-13-20210206","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2008.08496.x","article-title":"Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial","volume":"158","author":"Lee","year":"2008","journal-title":"Br J Dermatol"},{"key":"R45-13-20210206","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2133.2008.08702.x","article-title":"Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results","volume":"159","author":"Papageorgiou","year":"2008","journal-title":"Br J Dermatol"},{"key":"R46-13-20210206","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/lsm.20621","article-title":"Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser","volume":"40","author":"Bernstein","year":"2008","journal-title":"Lasers Surg Med"}],"container-title":["Current Opinion in Otolaryngology & Head & Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOO.0b013e32832d75e3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:59:02Z","timestamp":1786039142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00020840-200908000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/moo.0b013e32832d75e3","relation":{},"ISSN":["1068-9508"],"issn-type":[{"value":"1068-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}